OncoPep
Dr. Bae serves as an Instructor at Harvard Medical School/Dana Farber Cancer Institute. She formerly served as Chief Technology Officer of VaxOnco Inc.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
OncoPep
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell-focused technologies are designed to be used on their own or in combination with other immunotherapeutics.